X4 Pharmaceuticals Inc (XFOR)

1.04 +0.03 (+2.97%) USD  |  NASDAQ  |  Jun 10, 16:00
1.045 0.00 (0.00%) After-Hours: 20:00
More

X4 Pharmaceuticals Cash from Operations (Quarterly): -33.60M for March 31, 2024

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Upgrade now.
Date Value
March 31, 2024 -33.60M
December 31, 2023 -27.75M
September 30, 2023 -20.83M
June 30, 2023 -21.42M
March 31, 2023 -26.51M
December 31, 2022 -19.09M
September 30, 2022 -19.31M
June 30, 2022 -18.47M
March 31, 2022 -20.23M
December 31, 2021 -19.05M
September 30, 2021 -14.21M
June 30, 2021 -19.20M
March 31, 2021 -18.44M
December 31, 2020 -17.50M
September 30, 2020 -14.33M
Date Value
June 30, 2020 -11.46M
March 31, 2020 -15.53M
December 31, 2019 -9.241M
September 30, 2019 -12.77M
June 30, 2019 -14.29M
March 31, 2019 -11.75M
December 31, 2018 8.397M
September 30, 2018 -8.16M
June 30, 2018 -13.48M
March 31, 2018 -12.18M
December 31, 2017 -12.91M
September 30, 2017 -5.09M
June 30, 2017 -6.363M
March 31, 2017 -3.511M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-33.60M
Minimum
Mar 2024
-9.241M
Maximum
Dec 2019
-18.66M
Average
-18.76M
Median

Cash from Operations (Quarterly) Benchmarks

Phio Pharmaceuticals Corp -2.011M
Ocular Therapeutix Inc -33.89M
Alpine Immune Sciences Inc (DELISTED) -27.69M
Scholar Rock Holding Corp -49.78M
RAPT Therapeutics Inc -27.08M

Cash from Operations (Quarterly) Related Metrics

Cash from Investing (Quarterly) -5.322M
Free Cash Flow -103.71M
Free Cash Flow Per Share (Quarterly) -0.1683
Free Cash Flow Yield -52.16%